Innospec (IOSP) Expected to Announce Quarterly Earnings on Tuesday

Innospec (NASDAQ:IOSP) is expected to post its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect the company to announce earnings of $1.26 per share and revenue of $460.8670 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 18, 2026 at 9:00 AM ET.

Innospec Stock Down 0.3%

IOSP opened at $86.58 on Friday. Innospec has a 52 week low of $70.10 and a 52 week high of $112.74. The business has a 50 day moving average price of $80.42 and a two-hundred day moving average price of $79.14. The company has a market cap of $2.15 billion, a PE ratio of -2,886.00 and a beta of 0.91.

Hedge Funds Weigh In On Innospec

A number of large investors have recently bought and sold shares of IOSP. Goldman Sachs Group Inc. lifted its holdings in shares of Innospec by 71.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 484,968 shares of the specialty chemicals company’s stock worth $37,119,000 after purchasing an additional 202,325 shares during the last quarter. Millennium Management LLC raised its position in Innospec by 8,176.5% in the first quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock worth $16,147,000 after acquiring an additional 168,355 shares in the last quarter. Norges Bank acquired a new position in shares of Innospec in the 4th quarter worth $10,654,000. Qube Research & Technologies Ltd lifted its stake in shares of Innospec by 72.1% in the second quarter. Qube Research & Technologies Ltd now owns 306,761 shares of the specialty chemicals company’s stock valued at $25,796,000 after buying an additional 128,544 shares during the period. Finally, Victory Capital Management Inc. grew its position in Innospec by 13.7% during the fourth quarter. Victory Capital Management Inc. now owns 950,074 shares of the specialty chemicals company’s stock worth $72,719,000 after buying an additional 114,179 shares in the last quarter. Institutional investors own 96.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on IOSP shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Innospec in a report on Monday, December 22nd. Zacks Research upgraded shares of Innospec from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 6th. Finally, Wall Street Zen raised shares of Innospec from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Innospec has an average rating of “Reduce”.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.